Literature DB >> 18090421

Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis.

Bradley F Boeve1.   

Abstract

Frontotemporal lobar degeneration, corticobasal degeneration (CBD), progressive supranuclear palsy, and amyotrophic lateral sclerosis have been considered distinct clinicopathologic entities with few issues in common other than neurodegeneration being central to all. The aim of this paper is to highlight the clinical, topographic, pathologic, proteomic, and genetic similarities among these disorders and the syndromes through which each disorder is exhibited. The critical roles of tau and TAR DNA-binding protein 43 (TDP-43) dysfunction in the disorders and syndromes are emphasized. Although confusion certainly remains, and the ability to predict the underlying proteinopathy in the various neurodegenerative syndromes is far from perfect, there is optimism that insights gained over the next few years will enhance our ability to accurately identify the amyloidopathies, tauopathies, and TDP-43opathies early in the disease course, potentially improving the ability to impact these diseases once targeted therapies have been developed.

Entities:  

Mesh:

Year:  2007        PMID: 18090421     DOI: 10.1097/WAD.0b013e31815bf454

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  13 in total

Review 1.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

Review 2.  The corticobasal syndrome-Alzheimer's disease conundrum.

Authors:  Anhar Hassan; Jennifer L Whitwell; Keith A Josephs
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

Review 3.  The epidemiology of frontotemporal dementia.

Authors:  Chiadi U Onyike; Janine Diehl-Schmid
Journal:  Int Rev Psychiatry       Date:  2013-04

4.  Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion.

Authors:  Olga Pletnikova; Kelly L Sloane; Alan E Renton; Bryan J Traynor; Barbara J Crain; Tammy Reid; Tao Zu; Laura P W Ranum; Juan C Troncoso; Peter V Rabins; Chiadi U Onyike
Journal:  Neurobiol Aging       Date:  2014-04-18       Impact factor: 4.673

Review 5.  The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study.

Authors:  Bradley F Boeve
Journal:  J Mol Neurosci       Date:  2011-08-19       Impact factor: 3.444

6.  Symmetric corticobasal degeneration (S-CBD).

Authors:  Anhar Hassan; Jennifer L Whitwell; Bradley F Boeve; Clifford R Jack; Joseph E Parisi; Dennis W Dickson; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2009-12-16       Impact factor: 4.891

7.  Estimating severity of illness and disability in Frontotemporal Dementia: Preliminary analysis of the Dementia Disability Rating (DDR).

Authors:  Chiadi U Onyike; Kelly L Sloane; Shawn F Smyth; Brian S Appleby; David M Blass; Peter V Rabins
Journal:  Acta Neuropsychol       Date:  2011

8.  Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model.

Authors:  Theresa N T Dang; Carol Dobson-Stone; Elias N Glaros; Woojin S Kim; Marianne Hallupp; Lauren Bartley; Olivier Piguet; John R Hodges; Glenda M Halliday; Kay L Double; Peter R Schofield; Peter J Crouch; John B J Kwok
Journal:  Dis Model Mech       Date:  2013-06-20       Impact factor: 5.758

9.  Rapidly progressive corticobasal degeneration syndrome.

Authors:  Ana Herrero Valverde; Sónia Costa; Angela Timoteo; Ricardo Ginestal; José Pimentel
Journal:  Case Rep Neurol       Date:  2011-08-23

10.  Comparison of gait in progressive supranuclear palsy, Parkinson's disease and healthy older adults.

Authors:  Thorlene Egerton; David R Williams; Robert Iansek
Journal:  BMC Neurol       Date:  2012-10-02       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.